This page has not been authorized, sponsored, or otherwise approved or endorsed by the companies represented herein. Each of the company logos represented herein are trademarks of Microsoft Corporation; Dow Jones & Company; Nasdaq, Inc.; Forbes Media, LLC; Investor's Business Daily, Inc.; and Morningstar, Inc.
Copyright 2025 Zacks Investment Research | 101 N Wacker Drive, Floor 15, Chicago, IL 60606
At the center of everything we do is a strong commitment to independent research and sharing its profitable discoveries with investors. This dedication to giving investors a trading advantage led to the creation of our proven Zacks Rank stock-rating system. Since 1988 it has more than doubled the S&P 500 with an average gain of +23.64% per year. These returns cover a period from January 1, 1988 through August 4, 2025. Zacks Rank stock-rating system returns are computed monthly based on the beginning of the month and end of the month Zacks Rank stock prices plus any dividends received during that particular month. A simple, equally-weighted average return of all Zacks Rank stocks is calculated to determine the monthly return. The monthly returns are then compounded to arrive at the annual return. Only Zacks Rank stocks included in Zacks hypothetical portfolios at the beginning of each month are included in the return calculations. Zacks Ranks stocks can, and often do, change throughout the month. Certain Zacks Rank stocks for which no month-end price was available, pricing information was not collected, or for certain other reasons have been excluded from these return calculations. Zacks may license the Zacks Mutual Fund rating provided herein to third parties, including but not limited to the issuer.
Visit Performance Disclosure for information about the performance numbers displayed above.
Visit www.zacksdata.com to get our data and content for your mobile app or website.
Real time prices by BATS. Delayed quotes by Sungard.
NYSE and AMEX data is at least 20 minutes delayed. NASDAQ data is at least 15 minutes delayed.
This site is protected by reCAPTCHA and the Google Privacy Policy, DMCA Policy and Terms of Service apply.
Zacks News
GPK or ATR: Which Is the Better Value Stock Right Now?
by Zacks Equity Research
GPK vs. ATR: Which Stock Is the Better Value Option?
Should iShares MSCI USA SmallCap Min Vol Factor ETF (SMMV) Be on Your Investing Radar?
by Zacks Equity Research
Style Box ETF report for SMMV
SON vs. ATR: Which Stock Should Value Investors Buy Now?
by Zacks Equity Research
SON vs. ATR: Which Stock Is the Better Value Option?
Strength Seen in Sonoco (SON): Can Its 5.8% Jump Turn into More Strength?
by Zacks Equity Research
Sonoco (SON) was a big mover last session on higher-than-average trading volume. The latest trend in earnings estimate revisions might not help the stock continue moving higher in the near term.
SON vs. ATR: Which Stock Should Value Investors Buy Now?
by Zacks Equity Research
SON vs. ATR: Which Stock Is the Better Value Option?
SON or ATR: Which Is the Better Value Stock Right Now?
by Zacks Equity Research
SON vs. ATR: Which Stock Is the Better Value Option?
AptarGroup (ATR) Q4 Earnings and Revenues Beat Estimates
by Zacks Equity Research
AptarGroup's (ATR) fourth-quarter 2021 top line improves on solid performance across all segments.
AptarGroup (ATR) Tops Q4 Earnings and Revenue Estimates
by Zacks Equity Research
AptarGroup (ATR) delivered earnings and revenue surprises of 1.09% and 1.93%, respectively, for the quarter ended December 2021. Do the numbers hold clues to what lies ahead for the stock?
AptarGroup (ATR) Reports Next Week: What to Know Ahead of the Release
by Zacks Equity Research
AptarGroup (ATR) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
Grainger (GWW) to Release Q4 Earnings: Is a Beat in Store?
by Zacks Equity Research
Grainger's (GWW) Q4 performance is likely to reflect the benefits from strong growth in non-pandemic product sales, a surge in e-commerce sales and gains from cost-control actions.
Avery Dennison (AVY) to Report Q4 Earnings: What's in Store?
by Zacks Equity Research
Avery Dennison's (AVY) Q4 performance is likely to reflect higher demand for essential products and margin benefits from productivity and cost actions.
GEF or ATR: Which Is the Better Value Stock Right Now?
by Zacks Equity Research
GEF vs. ATR: Which Stock Is the Better Value Option?
AMCR or ATR: Which Is the Better Value Stock Right Now?
by Zacks Equity Research
AMCR vs. ATR: Which Stock Is the Better Value Option?
BERY vs. ATR: Which Stock Is the Better Value Option?
by Zacks Equity Research
BERY vs. ATR: Which Stock Is the Better Value Option?
AMCR or ATR: Which Is the Better Value Stock Right Now?
by Zacks Equity Research
AMCR vs. ATR: Which Stock Is the Better Value Option?
AptarGroup (ATR) Meets Q3 Earnings Estimates
by Zacks Equity Research
AptarGroup (ATR) delivered earnings and revenue surprises of 0.00% and 0.98%, respectively, for the quarter ended September 2021. Do the numbers hold clues to what lies ahead for the stock?
Analysts Estimate AptarGroup (ATR) to Report a Decline in Earnings: What to Look Out for
by Zacks Equity Research
AptarGroup (ATR) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
Should iShares MSCI USA SmallCap Min Vol Factor ETF (SMMV) Be on Your Investing Radar?
by Zacks Equity Research
Style Box ETF report for SMMV
GEF or ATR: Which Is the Better Value Stock Right Now?
by Zacks Equity Research
GEF vs. ATR: Which Stock Is the Better Value Option?
Should iShares MSCI USA SmallCap Min Vol Factor ETF (SMMV) Be on Your Investing Radar?
by Zacks Equity Research
Style Box ETF report for SMMV
GEF vs. ATR: Which Stock Is the Better Value Option?
by Zacks Equity Research
GEF vs. ATR: Which Stock Is the Better Value Option?
New Strong Sell Stocks for September 14th
by Zacks Equity Research
ATR, FTAI, HGEN, LMB, and MRSN have been added to the Zacks Rank #5 (Strong Sell) List on September 14, 2021.
AptarGroup (ATR) Buys Stake in Voluntis, Boosts Capabilities
by Zacks Equity Research
AptarGroup (ATR) completes the acquisition of 64.6% stake in Voluntis, which will help expand its digital healthcare offerings and drive innovation in the healthcare space.
GEF vs. ATR: Which Stock Should Value Investors Buy Now?
by Zacks Equity Research
GEF vs. ATR: Which Stock Is the Better Value Option?
AptarGroup (ATR) Shares Decline as Q2 Earnings Lag Estimates
by Zacks Equity Research
AptarGroup's (ATR) second-quarter 2021 top line improves on increased demand for the company's dispensing solutions.